Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Delve into Zero Based Budgeting For Families Case Studies to understand practical outcomes. This intro presents key takeaways you can implement.
21,984 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Ciena shares surged on Monday thanks to upbeat analyst revisions and higher price targets. This article breaks down w...
One of Wall Street’s hottest hedge funds is riding a two-trade surge, concentrated in Nvidia and Meta Platforms, as i...
CoreWeave has surged into the AI infrastructure spotlight, but the ride is not risk-free. This article analyzes the g...
When a company in niche hardware makes a bold strategic move, the stock can leap. This piece explains how unusual mac...
A JPMorgan client note argues that Strategy may purchase as much as $30 billion of Bitcoin in 2026, placing Bitcoin i...
After a strong rally, investors ask if AMD remains a smart bet. This in-depth look weighs AI roadmaps, growth drivers...
Explore the highlights from the (rlx) 2026 earnings call, including what drove revenue, how margins are shaping up, a...
PIMCO’s Multi Sector Bond Active ETF PYLD delivered a near-10% return over the past year, topping key bond indexes an...
Dogecoin has fallen under the 10-cent threshold amid a broad risk-off in crypto markets. With no single catalyst, tra...
A widow inherits a traditional IRA worth hundreds of thousands and must navigate year-of-death RMDs and future bracke...
Broadcom is slated to report fiscal Q2 results after the market closes today, with investors focusing on AI-driven re...